Secondary Logo

Journal Logo

Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics

Drawbacks of Its Clinical Application

Erratum

Therapeutic Drug Monitoring: December 2019 - Volume 41 - Issue 6 - p 772
doi: 10.1097/FTD.0000000000000712
Erratum
Free

Received October 23, 2019

Accepted October 23, 2019

In the June 2018 issue of Therapeutic Drug Monitoring, in the article “Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics: Drawbacks of Its Clinical Application” by Kloosterboer et al., the authors have noted an error in formula 2 (page 345). The correct formula should read:

Additionally, the agreement was checked with formula 3:

The revised table 2 and 3 are included below. The adjustments have no influence on the main findings nor conclusions of the article.

Table 2

Table 2

Table 3

Table 3

Furthermore, the correct affiliations for Sanne M. Kloosterboer, MD are the Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands, and the Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC, Rotterdam, the Netherlands.

Back to Top | Article Outline

REFERENCE

Kloosterboer SM, de Winter BCM, Bahmany S, et al Dried blood spot analysis for therapeutic drug monitoring of antipsychotics: drawbacks of its clinical application. Ther Drug Monit. 2018;40:344–350.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.